Salinosporamide A - an overview | ScienceDirect Topics
Structures of marizomib and its analogs and mechanism of proteasome... | Download Scientific Diagram
Cancers | Free Full-Text | Proteasome Inhibitors for the Treatment of Multiple Myeloma | HTML
Molecular Mechanisms of Acquired Proteasome Inhibitor Resistance | Journal of Medicinal Chemistry
Salinosporamide A - Wikipedia
Resistance to proteasome inhibitors and other targeted therapies in myeloma - Wallington‐Beddoe - 2018 - British Journal of Haematology - Wiley Online Library
Proteasome Inhibitors, Refined | Science | AAAS
Marizomib | C15H20ClNO4 - PubChem
Salinosporamide A - Wikipedia
Marizomib suppresses triple-negative breast cancer via proteasome and oxidative phosphorylation inhibition
Overcoming drug resistance by targeting protein homeostasis in multiple myeloma
New investigational drugs with single-agent activity in multiple myeloma | Blood Cancer Journal
Development of Novel Epoxyketone-Based Proteasome Inhibitors as a Strategy To Overcome Cancer Resistance to Carfilzomib and Bortezomib | Journal of Medicinal Chemistry
Molecules | Free Full-Text | Proteasome Inhibitors: Harnessing Proteostasis to Combat Disease | HTML
Proteasome Inhibitors as Sensitizing Agents for Cancer Chemotherapy - ScienceDirect
Frontiers | The Role of Proteasome Inhibitors in Treating Acute Lymphoblastic Leukaemia | Oncology
Pomalidomide in the treatment of multiple myeloma: design, development | DDDT
Exploring the role and clinical implications of proteasome inhibition in medulloblastoma - Hoerig - 2021 - Pediatric Blood & Cancer - Wiley Online Library
Proteasome Regulator Marizomib (NPI-0052) Exhibits Prolonged Inhibition, Attenuated Efflux, and Greater Cytotoxicity than Its Reversible Analogs | Journal of Pharmacology and Experimental Therapeutics
Advances in the understanding of mechanisms and therapeutic use of bortezomib. - Abstract - Europe PMC
Overcoming drug resistance by targeting protein homeostasis in multiple myeloma
New Proteasome Inhibitors in Myeloma | SpringerLink
Advances in the understanding of mechanisms and therapeutic use of bortezomib. - Abstract - Europe PMC
Structure and mechanism of action of proteasome inhibitors. (A)... | Download Scientific Diagram
Frontiers | Soluble and Cell–Cell-Mediated Drivers of Proteasome Inhibitor Resistance in Multiple Myeloma | Endocrinology
